|
Time
to Market
Technology,
regulatory, healthcare policies have a strong influence in
development and commercialization of medical devices. Time to
market is a challenging issue which require perfect planning and
implementation to soar in the existing medical devices market.
-
Disruptive
technologies may necessitate new selling channels.
-
Time
consuming regulatory approval may be required for new
technologies.
-
Exploding
healthcare costs may constraint new innovative medical devices to
administrative and insurance hurdles to obtain reimbursment approval.
|
|
|
|
Technology
The future orientation of technology has to be examined cautiously
and regularly. Watch for discontinuities resp. disruptive
technologies to take the right turn at the right moment.
Knowledge
and innovation management as well as market intelligence play a key
role in being flexible to changes.
For
example progress in molecular biology/genetics delivered non
biological solutions to clinical problems as ultrasound appliances
for tissue repair. |
|
|
Regulatory
Global
regulations from the FDA/CDRH or the EEC are balanced by local
regulations as for example the MPG in Germany or the regulatory in
Japan. Inconsistent requirements between markets can contribute to
slow down the approval process. The innovation process should
reflect the requirements of the regulatory to guarantee success of
approval.
Moreover, biological
(cell)
based solutions can be seen as medicinal products (i.e.
pharmaceutical products or drugs) submitted to other regulatory. New
biological products are often on the edge between medical devices
and drugs, necessitating profound knowledge of both regulatory
contents to get approval. |
|
|
Healthcare
Acceptancy
of new devices is often linked to reimbursment issues. Evidence
based medicine plays a major role in getting approval of insurances
or national healthcare system for reimbursment. The costly and time
consuming challenge consists in generating the cost-effectiveness
evidence and establish the reimbursment process.
New
innovative devices may necessitate re-education in clinical practice. |
|
|
Expectations
vs. Reality
The
often observed discrepancy between expectations and reality extend
over the whole medical devices market.
Innovation can be defined as a successeful product fulfilling most of the requirements defined by
users, i.e. when reality meets expectations from the perspective of
the user.
A particular care has to be taken in establishing an attractive
concept for a new product. Success is only guaranteed when the
balance between marketing pull and technology push is reached,
offering useful information about markets, competitors, and
available and coming technologies. Thus the product will satisfy the
demand.
|
|
|
|
Innovation
is fed by success fed by innovation !
|